164 related articles for article (PubMed ID: 37012656)
1. DNA content abnormality frequently develops in the right/proximal colon in patients with primary sclerosing cholangitis and inflammatory bowel disease and is highly predictive of subsequent detection of dysplasia.
Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Histopathology; 2023 Jul; 83(1):116-125. PubMed ID: 37012656
[TBL] [Abstract][Full Text] [Related]
2. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Zhang R; Lauwers GY; Choi WT
J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
[TBL] [Abstract][Full Text] [Related]
3. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
[TBL] [Abstract][Full Text] [Related]
5. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
[TBL] [Abstract][Full Text] [Related]
7. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
8. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
9. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
10. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
11. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
Broomé U; Löfberg R; Lundqvist K; Veress B
Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
[TBL] [Abstract][Full Text] [Related]
12. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis.
Shaw DG; Aguirre-Gamboa R; Vieira MC; Gona S; DiNardi N; Wang A; Dumaine A; Gelderloos-Arends J; Earley ZM; Meckel KR; Ciszewski C; Castillo A; Monroe K; Torres J; Shah SC; Colombel JF; Itzkowitz S; Newberry R; Cohen RD; Rubin DT; Quince C; Cobey S; Jonkers IH; Weber CR; Pekow J; Wilson PC; Barreiro LB; Jabri B
Nat Med; 2023 Jun; 29(6):1520-1529. PubMed ID: 37322120
[TBL] [Abstract][Full Text] [Related]
13. Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis.
Jamil OK; Shaw D; Deng Z; Dinardi N; Fillman N; Khanna S; Krugliak Cleveland N; Sakuraba A; Weber CR; Cohen RD; Dalal S; Jabri B; Rubin DT; Pekow J
Therap Adv Gastroenterol; 2023; 16():17562848231184985. PubMed ID: 37692199
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
Zheng HH; Jiang XL
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.
Sano H; Nakazawa T; Ando T; Hayashi K; Naitoh I; Okumura F; Miyabe K; Yoshida M; Takahashi S; Ohara H; Joh T
J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):154-61. PubMed ID: 20740366
[TBL] [Abstract][Full Text] [Related]
16. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
17. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
[TBL] [Abstract][Full Text] [Related]
18. Dysplasia Detected in Patients With Serrated Epithelial Change Is Frequently Associated With an Invisible or Flat Endoscopic Appearance, Nonconventional Dysplastic Features, and Advanced Neoplasia.
Bahceci D; Alpert L; Storozuk T; Liao X; Yozu M; Westerhoff M; Kővári BP; Lauwers GY; Choi WT
Am J Surg Pathol; 2024 Jun; ():. PubMed ID: 38907614
[TBL] [Abstract][Full Text] [Related]
19. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis.
Bajer L; Wohl P; Drastich P
Vnitr Lek; 2018; 64(6):659-664. PubMed ID: 30223664
[TBL] [Abstract][Full Text] [Related]
20. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
